日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)

共济失调毛细血管扩张症和 Rad3 相关抑制剂 berzosertib 与伊立替康联合治疗晚期实体瘤患者的 1 期临床试验 (ETCTN 9938)

Villaruz, Liza C; Jin, Jingxiao; Wang, Hong; Lee, James J; Luke, Jason J; Rhee, John C; Waqar, Saiama N; Shapiro, Geoffrey I; Cleary, James; Davar, Diwakar; Burns, Timothy F; Verma, Rashmi; Amin, Manik; Appleman, Leonard; Ciombor, Kristen K; Davis, Elizabeth J; Riess, Jonathan W; Dees, E Claire; Kim, Edward J; Cardin, Dana; Guo, Jianxia; Christner, Susan M; Deppas, Joshua; Parise, Angelina M; Schmitz, John C; Guerrouahen, Bella S; Suchko, Michael; Contreras, Alejandro; Li, Li; Ferry-Galow, Katherine V; Chang, Ting-Chia; Jiwani, Shahanawaz; Bakkenist, Christopher J; Chu, Edward; Gore, Steven D; Beumer, Jan H

Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiation

ATR抑制剂ceralasertib、elimusertib和berzosertib单独使用及与电离辐射联合使用时的体内毒理学比较

Deppas, Joshua J; Kiesel, Brian F; Guo, Jianxia; Rigatti, Lora H; Latoche, Joseph D; Green, Anthony; Knizner, Paul; Clump, D Andy; Pandya, Pinakin; Vendetti, Frank P; Bakkenist, Christopher J; Beumer, Jan H

Mitigation of Fetal Radiation Injury from Mid-Gestation Total-body Irradiation by Maternal Administration of Mitochondrial-Targeted GS-Nitroxide JP4-039.

通过母体注射线粒体靶向 GS-硝基氧化物减轻妊娠中期全身照射对胎儿的辐射损伤 JP4-039

Wu Yijen L, Christodoulou Anthony G, Beumer Jan H, Rigatti Lora H, Fisher Renee, Ross Mark, Watkins Simon, Cortes Devin R E, Ruck Cody, Manzoor Shanim, Wyman Samuel K, Stapleton Margaret C, Goetzman Eric, Bharathi Sivakama, Wipf Peter, Wang Hong, Tan Tuantuan, Christner Susan M, Guo Jianxia, Lo Cecilia W Y, Epperly Michael W, Greenberger Joel S

Murine toxicology and pharmacokinetics of lead next generation galeterone analog, VNPP433-3β

下一代加列酮类似物VNPP433-3β的鼠毒理学和药代动力学研究

Thomas, Elizabeth; Thankan, Retheesh S; Purushottamachar, Puranik; Guo, Jianxia; Parise, Robert A; Beumer, Jan H; Njar, Vincent C O

Modular Smart Molecules for PSMA-Targeted Chemotherapy

用于PSMA靶向化疗的模块化智能分子

Olatunji, Feyisola P; Pun, Michael; Herman, Jacob W; Romero, Oscar; Maniatopoulos, Mitchell; Latoche, Joseph D; Parise, Robert A; Guo, Jianxia; Beumer, Jan H; Anderson, Carolyn J; Berkman, Clifford E

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

二次细胞减灭术联合卡铂腹腔热灌注化疗治疗铂敏感复发性卵巢癌:MSK团队卵巢II期研究

Zivanovic, Oliver; Chi, Dennis S; Zhou, Qin; Iasonos, Alexia; Konner, Jason A; Makker, Vicky; Grisham, Rachel N; Brown, Amy K; Nerenstone, Stacy; Diaz, John P; Schroeder, Eric D; Langstraat, Carrie L; Paroder, Viktoriya; Lakhman, Yulia; Soldan, Krysten; Su, Katy; Gardner, Ginger J; Andikyan, Vaagn; Guo, Jianxia; Jewell, Elizabeth L; Long Roche, Kara; Troso-Sandoval, Tiffany; Lichtman, Stuart M; Moukarzel, Lea A; Dessources, Kimberly; Abu-Rustum, Nadeem R; Aghajanian, Carol; Tew, William P; Beumer, Jan; Sonoda, Yukio; O'Cearbhaill, Roisin E

Liquid chromatography-tandem mass spectrometric assay for the quantitation of the novel radiation protective agent and radiation mitigator JP4-039 in murine plasma

采用液相色谱-串联质谱法定量分析小鼠血浆中新型辐射防护剂和辐射缓解剂JP4-039的含量

Christner, Susan; Guo, Jianxia; Parise, Robert A; Ringeval, Melanie; Hoye, Adam T; Wipf, Peter; Epperly, Michael W; Greenberger, Joel S; Beumer, Jan H; Eiseman, Julie L

Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation

一种新型IL-6诱导STAT3激活抑制剂的毒性、药代动力学和代谢研究

Kiesel, Brian F; Parise, Robert A; Guo, Jianxia; Huryn, Donna M; Johnston, Paul A; Colombo, Raffaele; Sen, Malabika; Grandis, Jennifer R; Beumer, Jan H; Eiseman, Julie L